Skip to content
healthcare.dev

HYCAMTIN

NDC 0078-0674, topotecan hydrochloride, injection, powder, lyophilized, for solution, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0674
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020671
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0674 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOPOTECAN HYDROCHLORIDE4 mg/4mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
0078-0674-61000780674611 VIAL, SINGLE-DOSE in 1 CARTON (0078-0674-61) / 4 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/eeee060c-a9ec-423e-a374-8484009f8524

Use it

Look up 0078-0674 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0674 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0674. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.